Anne Samuel
Stock Analyst at JP Morgan
(3.30)
# 1,051
Out of 4,755 analysts
60
Total ratings
51.28%
Success rate
3.38%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $15 → $13 | $9.86 | +31.85% | 11 | Jan 28, 2025 | |
| PGNY Progyny | Maintains: Neutral | $17 → $23 | $22.39 | +2.72% | 7 | Jan 28, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $208 → $218 | $234.33 | -6.97% | 5 | Dec 16, 2024 | |
| DOCS Doximity | Maintains: Neutral | $30 → $48 | $74.94 | -35.95% | 5 | Nov 21, 2024 | |
| OMCL Omnicell | Maintains: Neutral | $37 → $44 | $41.25 | +6.67% | 4 | Nov 21, 2024 | |
| IQV IQVIA Holdings | Maintains: Overweight | $279 → $240 | $200.89 | +19.47% | 5 | Nov 5, 2024 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $28.56 | -1.96% | 2 | Sep 9, 2024 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $18.52 | +2.59% | 4 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $28.91 | -27.36% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $5.50 | +136.36% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $42.48 | -36.44% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $5.30 | -5.66% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $86 → $108 | $112.46 | -3.97% | 8 | Apr 2, 2024 |
Evolent Health
Jan 28, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $9.86
Upside: +31.85%
Progyny
Jan 28, 2025
Maintains: Neutral
Price Target: $17 → $23
Current: $22.39
Upside: +2.72%
Veeva Systems
Dec 16, 2024
Maintains: Neutral
Price Target: $208 → $218
Current: $234.33
Upside: -6.97%
Doximity
Nov 21, 2024
Maintains: Neutral
Price Target: $30 → $48
Current: $74.94
Upside: -35.95%
Omnicell
Nov 21, 2024
Maintains: Neutral
Price Target: $37 → $44
Current: $41.25
Upside: +6.67%
IQVIA Holdings
Nov 5, 2024
Maintains: Overweight
Price Target: $279 → $240
Current: $200.89
Upside: +19.47%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $28.56
Upside: -1.96%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $18.52
Upside: +2.59%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $28.91
Upside: -27.36%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $5.50
Upside: +136.36%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $42.48
Upside: -36.44%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $5.30
Upside: -5.66%
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $112.46
Upside: -3.97%